Annual Revenue
$2.50 B
+$415.49 M+19.93%
31 December 2023
Summary:
Exact Sciences annual revenue is currently $2.50 billion, with the most recent change of +$415.49 million (+19.93%) on 31 December 2023. During the last 3 years, it has risen by +$1.01 billion (+67.61%). EXAS annual revenue is now at all-time high.EXAS Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$708.65 M
+$9.39 M+1.34%
30 September 2024
Summary:
Exact Sciences quarterly revenue is currently $708.65 million, with the most recent change of +$9.39 million (+1.34%) on 30 September 2024. Over the past year, it has increased by +$80.32 million (+12.78%). EXAS quarterly revenue is now at all-time high.EXAS Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$2.69 B
+$80.32 M+3.07%
30 September 2024
Summary:
Exact Sciences TTM revenue is currently $2.69 billion, with the most recent change of +$80.32 million (+3.07%) on 30 September 2024. Over the past year, it has increased by +$286.45 million (+11.91%). EXAS TTM revenue is now at all-time high.EXAS TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EXAS Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +19.9% | +12.8% | +11.9% |
| 3 y3 years | +67.6% | +55.3% | +53.0% |
| 5 y5 years | +450.1% | +223.9% | +272.0% |
EXAS Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +67.6% | at high | +55.3% | at high | +53.0% |
| 5 y | 5 years | at high | +450.1% | at high | +223.9% | at high | +272.0% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% |
Exact Sciences Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $708.65 M(+1.3%) | $2.69 B(+3.1%) |
| June 2024 | - | $699.26 M(+9.7%) | $2.61 B(+3.0%) |
| Mar 2024 | - | $637.52 M(-1.4%) | $2.53 B(+1.4%) |
| Dec 2023 | $2.50 B(+19.9%) | $646.88 M(+3.0%) | $2.50 B(+3.9%) |
| Sept 2023 | - | $628.34 M(+1.0%) | $2.41 B(+4.6%) |
| June 2023 | - | $622.09 M(+3.3%) | $2.30 B(+4.6%) |
| Mar 2023 | - | $602.45 M(+8.9%) | $2.20 B(+5.6%) |
| Dec 2022 | $2.08 B(+17.9%) | $553.00 M(+5.7%) | $2.08 B(+3.9%) |
| Sept 2022 | - | $523.07 M(+0.3%) | $2.01 B(+3.4%) |
| June 2022 | - | $521.64 M(+7.2%) | $1.94 B(+4.7%) |
| Mar 2022 | - | $486.57 M(+2.7%) | $1.85 B(+4.8%) |
| Dec 2021 | $1.77 B(+18.5%) | $473.81 M(+3.8%) | $1.77 B(+0.4%) |
| Sept 2021 | - | $456.38 M(+5.0%) | $1.76 B(+2.8%) |
| June 2021 | - | $434.82 M(+8.1%) | $1.71 B(+10.7%) |
| Mar 2021 | - | $402.08 M(-13.8%) | $1.55 B(+3.6%) |
| Dec 2020 | $1.49 B(+70.2%) | $466.34 M(+14.2%) | $1.49 B(+12.9%) |
| Sept 2020 | - | $408.36 M(+51.9%) | $1.32 B(+16.8%) |
| June 2020 | - | $268.87 M(-22.7%) | $1.13 B(+6.5%) |
| Mar 2020 | - | $347.82 M(+17.7%) | $1.06 B(+21.2%) |
| Dec 2019 | $876.29 M(+92.8%) | $295.57 M(+35.1%) | $876.29 M(+21.1%) |
| Sept 2019 | - | $218.81 M(+9.5%) | $723.70 M(+16.1%) |
| June 2019 | - | $199.87 M(+23.3%) | $623.18 M(+18.4%) |
| Mar 2019 | - | $162.04 M(+13.3%) | $526.21 M(+15.8%) |
| Dec 2018 | $454.46 M(+70.9%) | $142.98 M(+20.9%) | $454.46 M(+13.9%) |
| Sept 2018 | - | $118.29 M(+15.0%) | $398.89 M(+12.9%) |
| June 2018 | - | $102.89 M(+14.0%) | $353.17 M(+14.7%) |
| Mar 2018 | - | $90.30 M(+3.3%) | $307.92 M(+15.8%) |
| Dec 2017 | $265.99 M(+167.7%) | $87.41 M(+20.4%) | $265.99 M(+24.4%) |
| Sept 2017 | - | $72.57 M(+25.9%) | $213.82 M(+26.3%) |
| June 2017 | - | $57.65 M(+19.2%) | $169.37 M(+27.4%) |
| Mar 2017 | - | $48.36 M(+37.2%) | $132.90 M(+33.7%) |
| Dec 2016 | $99.38 M(+152.0%) | $35.24 M(+25.3%) | $99.38 M(+26.5%) |
| Sept 2016 | - | $28.11 M(+32.7%) | $78.56 M(+24.5%) |
| June 2016 | - | $21.18 M(+42.8%) | $63.07 M(+26.1%) |
| Mar 2016 | - | $14.84 M(+2.9%) | $50.01 M(+26.8%) |
| Dec 2015 | $39.44 M(+2093.4%) | $14.42 M(+14.2%) | $39.44 M(+48.7%) |
| Sept 2015 | - | $12.63 M(+55.6%) | $26.52 M(+90.9%) |
| June 2015 | - | $8.12 M(+90.3%) | $13.89 M(+140.7%) |
| Mar 2015 | - | $4.27 M(+183.6%) | $5.77 M(+220.9%) |
| Dec 2014 | $1.80 M(-56.6%) | $1.50 M(+411.6%) | $1.80 M(-47.1%) |
| Mar 2014 | - | $294.00 K(-71.6%) | $3.40 M(-17.9%) |
| Dec 2013 | $4.14 M(0.0%) | $1.04 M(0.0%) | $4.14 M(0.0%) |
| Sept 2013 | - | $1.04 M(0.0%) | $4.14 M(0.0%) |
| June 2013 | - | $1.04 M(0.0%) | $4.14 M(0.0%) |
| Mar 2013 | - | $1.04 M(0.0%) | $4.14 M(0.0%) |
| Dec 2012 | $4.14 M | $1.04 M(0.0%) | $4.14 M(-0.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2012 | - | $1.04 M(0.0%) | $4.15 M(-0.1%) |
| June 2012 | - | $1.04 M(0.0%) | $4.15 M(-0.1%) |
| Mar 2012 | - | $1.04 M(-0.6%) | $4.16 M(-0.1%) |
| Dec 2011 | $4.16 M(-22.1%) | $1.04 M(+0.3%) | $4.16 M(-7.4%) |
| Sept 2011 | - | $1.04 M(-0.3%) | $4.50 M(-6.6%) |
| June 2011 | - | $1.04 M(+0.2%) | $4.81 M(-5.3%) |
| Mar 2011 | - | $1.04 M(-24.4%) | $5.08 M(-4.8%) |
| Dec 2010 | $5.34 M(+12.3%) | $1.38 M(+1.4%) | $5.34 M(+2.5%) |
| Sept 2010 | - | $1.36 M(+3.2%) | $5.21 M(+2.0%) |
| June 2010 | - | $1.31 M(+1.2%) | $5.11 M(+1.1%) |
| Mar 2010 | - | $1.30 M(+4.4%) | $5.06 M(+6.3%) |
| Dec 2009 | $4.76 M(-648.8%) | $1.24 M(-1.0%) | $4.76 M(+194.1%) |
| Sept 2009 | - | $1.26 M(-0.2%) | $1.62 M(+131.5%) |
| June 2009 | - | $1.26 M(+25.8%) | $699.00 K(-225.0%) |
| Mar 2009 | - | $1.00 M(-152.7%) | -$559.00 K(-62.9%) |
| Dec 2008 | -$867.00 K(-129.5%) | -$1.90 M(-662.6%) | -$1.51 M(-263.0%) |
| Sept 2008 | - | $337.00 K(+560.8%) | $925.00 K(-49.1%) |
| Mar 2008 | - | $51.00 K(-90.5%) | $1.82 M(-38.1%) |
| Dec 2007 | $2.94 M(-38.2%) | $537.00 K(+375.2%) | $2.94 M(-18.0%) |
| Sept 2007 | - | $113.00 K(-89.9%) | $3.58 M(-22.6%) |
| June 2007 | - | $1.11 M(-4.7%) | $4.62 M(-2.2%) |
| Mar 2007 | - | $1.17 M(-0.8%) | $4.73 M(-0.5%) |
| Dec 2006 | $4.75 M(+11.8%) | $1.18 M(+2.2%) | $4.75 M(-0.1%) |
| Sept 2006 | - | $1.16 M(-5.4%) | $4.75 M(-0.8%) |
| June 2006 | - | $1.22 M(+2.3%) | $4.79 M(+14.2%) |
| Mar 2006 | - | $1.19 M(+0.8%) | $4.20 M(-1.2%) |
| Dec 2005 | $4.25 M(-13.9%) | $1.19 M(-0.8%) | $4.25 M(-2.1%) |
| Sept 2005 | - | $1.20 M(+91.8%) | $4.34 M(-1.5%) |
| June 2005 | - | $623.00 K(-50.0%) | $4.41 M(-12.0%) |
| Mar 2005 | - | $1.25 M(-2.2%) | $5.00 M(+1.4%) |
| Dec 2004 | $4.93 M(+70.1%) | $1.27 M(+1.1%) | $4.93 M(+2.2%) |
| Sept 2004 | - | $1.26 M(+3.2%) | $4.83 M(+7.6%) |
| June 2004 | - | $1.22 M(+3.8%) | $4.49 M(+22.2%) |
| Mar 2004 | - | $1.18 M(+0.7%) | $3.67 M(+26.5%) |
| Dec 2003 | $2.90 M(+223.4%) | $1.17 M(+27.3%) | $2.90 M(+35.5%) |
| Sept 2003 | - | $918.00 K(+126.1%) | $2.14 M(+31.2%) |
| June 2003 | - | $406.00 K(-0.5%) | $1.63 M(+28.9%) |
| Mar 2003 | - | $408.00 K(-0.1%) | $1.27 M(+41.1%) |
| Dec 2002 | $897.00 K(+1658.8%) | $408.30 K(-0.3%) | $897.10 K(+70.3%) |
| Sept 2002 | - | $409.50 K(+923.8%) | $526.70 K(+304.2%) |
| June 2002 | - | $40.00 K(+1.8%) | $130.30 K(+44.3%) |
| Mar 2002 | - | $39.30 K(+3.7%) | $90.30 K(+77.1%) |
| Dec 2001 | $51.00 K | $37.90 K(+189.3%) | $51.00 K(+289.3%) |
| Sept 2001 | - | $13.10 K(>+9900.0%) | $13.10 K(>+9900.0%) |
| June 2001 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2001 | - | $0.00 | $0.00 |
FAQ
- What is Exact Sciences annual revenue?
- What is the all time high annual revenue for Exact Sciences?
- What is Exact Sciences annual revenue year-on-year change?
- What is Exact Sciences quarterly revenue?
- What is the all time high quarterly revenue for Exact Sciences?
- What is Exact Sciences quarterly revenue year-on-year change?
- What is Exact Sciences TTM revenue?
- What is the all time high TTM revenue for Exact Sciences?
- What is Exact Sciences TTM revenue year-on-year change?
What is Exact Sciences annual revenue?
The current annual revenue of EXAS is $2.50 B
What is the all time high annual revenue for Exact Sciences?
Exact Sciences all-time high annual revenue is $2.50 B
What is Exact Sciences annual revenue year-on-year change?
Over the past year, EXAS annual revenue has changed by +$415.49 M (+19.93%)
What is Exact Sciences quarterly revenue?
The current quarterly revenue of EXAS is $708.65 M
What is the all time high quarterly revenue for Exact Sciences?
Exact Sciences all-time high quarterly revenue is $708.65 M
What is Exact Sciences quarterly revenue year-on-year change?
Over the past year, EXAS quarterly revenue has changed by +$80.32 M (+12.78%)
What is Exact Sciences TTM revenue?
The current TTM revenue of EXAS is $2.69 B
What is the all time high TTM revenue for Exact Sciences?
Exact Sciences all-time high TTM revenue is $2.69 B
What is Exact Sciences TTM revenue year-on-year change?
Over the past year, EXAS TTM revenue has changed by +$286.45 M (+11.91%)